Therapeutic Proteins and Oral Vaccines Market
Therapeutic Proteins and Oral Vaccines Market
Scope: Industry Analysis, Market Size, Growth, Trends Till 2031
Request Sample Report
Therapeutic Proteins and Oral Vaccines Market Size and Growth
The Therapeutic Proteins and Oral Vaccines market is experiencing significant growth, driven by advancements in biotechnology and rising healthcare needs. The global therapeutic proteins market is valued at approximately $200 billion, while the oral vaccines segment is projected to reach $15 billion by 2026, reflecting increased demand for innovative treatments and preventive measures.
Request Sample Report
Companies Covered
(Covid 19 Impact Covered)
◍ Abbott
◍ Amgen
◍ Biogen
◍ Eli Lilly and Company
◍ Roche
◍ Johnson and Johnson
◍ Merck
◍ Novo Nordisk
◍ Pfizer
◍ Sanofi
◍ Serum Institute of India
◍ Emergent Biosolutions
◍ TransAlgae
◍ MigVax
◍ Lumen Bioscience
The therapeutic proteins and oral vaccines market features key players such as Abbott, Amgen, and Pfizer, leveraging innovative biological therapies and vaccine technologies. These companies drive market growth through R&D, strategic partnerships, and extensive pipelines. Notable 2022 revenues include Pfizer ($100B), Amgen ($25B), and Johnson & Johnson ($94B).
Request Sample Report
Market Segmentation
By Application
◍ Hospital Pharmacies
◍ Retail Pharmacies
◍ Online Pharmacies
By Product
◍ Therapeutic Proteins
◍ Oral Vaccines
Request Sample Report
Market Growth
Request Sample Report
$ X Billion USD
